A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement
Abstract Objective To explore the role of genetic testing of VKORC1 and CYP2C9 in determining the dosage of warfarin after aortic valve replacement. Methods A total of 172 patients receiving warfarin after aortic valve replacement were divided into a control group (n = 86) and an experimental (n = 8...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-04-01
|
| Series: | BMC Cardiovascular Disorders |
| Online Access: | https://doi.org/10.1186/s12872-022-02620-x |